PRIA Logo™
IdahoH 07772026 regular legislative sessionHouse

UNIFORM CONTROLLED SUBSTANCES – Amends existing law to revise provisions regarding controlled substances.

Sponsored By: HEALTH AND WELFARE COMMITTEE

Signed by Governor

UNIFORM CONTROLLED SUBSTANCES

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

4 provisions identified: 1 benefits, 0 costs, 3 mixed.

Check database before opioids or benzos

Beginning July 1, 2026, prescribers or their delegates must check your last 12 months in the state prescription database before giving an outpatient opioid or benzodiazepine. This rule does not apply to inpatient care, hospice, skilled nursing, emergency scenes or ambulances, or to prescriptions meant to last three days or less. The goal is safer prescribing and fewer dangerous drug interactions.

Stronger oversight for controlled-drug registrants

Registration now runs every two years for people who make, distribute, prescribe, administer, or research controlled drugs. Licensed drug outlets do not need a separate controlled‑substance registration. Registrants must keep records, inventories, and storage in line with state and federal law. The board can fine up to $2,000 per occurrence and recover illicit profits and prosecution/administrative costs. If your registration is restricted, suspended, or revoked, your controlled drugs are sealed during appeals and can be forfeited after a final revocation for transfer to a reverse distributor. Practitioners may issue or fill controlled‑substance prescriptions only if they meet state and federal law. Dispensing practitioners must label packages as Idaho law requires.

Idaho updates controlled drug schedules

The law expands Schedule I to cover many fentanyl‑related substances and other emerging drugs. It updates Schedules III–V, including set limits for narcotic combinations and adding drugs such as buprenorphine (Schedule III), tramadol (Schedule IV), and several newer anti‑seizure and migraine medicines (Schedule V). These listings change how products can be prescribed, dispensed, and enforced in Idaho. These changes take effect July 1, 2026.

Prescription database access and privacy rules

Beginning July 1, 2026, patients can see their own prescription records with ID and can name a designee using a notarized or certified release. More clinical staff can be set up as delegates, including health‑care staff, students, registered graduates, and registered pharmacy technicians, if a supervising prescriber or pharmacist designates them and they register. Peace officers and prosecuting officials can access data only when enforcing controlled‑substance laws. The division may decide whether to share data with listed groups and can block access if it believes data may be used illegally. Knowingly misusing or wrongly disclosing database data, or sharing your login, is a misdemeanor with up to six months in county jail, a fine up to $2,000, or both. The division can also require more prescriptions to be filed electronically and sets the format. The law removes the blanket statutory mandate for pharmacists and prescribers to register for online access; the division still controls how access works.

Sponsors & Cosponsors

Sponsor

  • HEALTH AND WELFARE COMMITTEE

    Affiliation unavailable

Cosponsors

  • Marco Adam Erickson

    Republican • House

  • Brandon Shippy

    Republican • Senate

Roll Call Votes

All Roll Calls

Yes: 99 • No: 1

Senate vote • 3/17/2026

Senate Floor Vote

Yes: 34 • No: 0

House vote • 3/2/2026

House Floor Vote

Yes: 65 • No: 1

Actions Timeline

  1. Reported Signed by Governor on March 20, 2026 Session Law Chapter 90 Effective: 07/01/2026

    3/23/2026

  2. Delivered to Governor at 4:32 p.m. on March 19, 2026

    3/20/2026

  3. Returned Signed by the President; Ordered Transmitted to Governor

    3/19/2026Senate

  4. Signed by President; returned to House

    3/19/2026Senate

  5. Received from the House enrolled/signed by Speaker

    3/19/2026Senate

  6. Reported Enrolled; Signed by Speaker; Transmitted to Senate

    3/18/2026House

  7. Returned from Senate Passed; to JRA for Enrolling

    3/18/2026House

  8. Read third time in full – PASSED - 34-0-1

    3/17/2026Senate

  9. Retained on calendar

    3/17/2026Senate

  10. Retained on calendar

    3/16/2026Senate

  11. Read second time; filed for Third Reading

    3/10/2026Senate

  12. Reported out of Committee with Do Pass Recommendation; Filed for second reading

    3/9/2026Senate

  13. Introduced, read first time; referred to: Health & Welfare

    3/3/2026Senate

  14. Received from the House passed; filed for first reading

    3/3/2026Senate

  15. Read Third Time in Full – PASSED - 65-1-4

    3/2/2026House

  16. Read second time; Filed for Third Reading

    2/27/2026House

  17. Reported Printed; Filed for Second Reading

    2/26/2026House

  18. Introduced, read first time, referred to JRA for Printing

    2/25/2026House

Bill Text

Related Bills

Back to State Legislation